PCOS and Infertility in Women

Imagine spending years quietly wondering why your body feels like it is working against you. Irregular periods — or none at all. Skin that breaks out like you are still in high school. Hair where you did not expect it, and thinning where you want it most. Weight that seems impossible to shift despite every effort. And then, when you finally decide you want to start a family, the news that what you have been living with has a name — Polycystic Ovary Syndrome — and that it is one of the leading causes of female infertility in the world.

This is the reality for a staggering number of women. PCOS is not a rare condition whispered about in specialist clinics. It is a widespread, often misunderstood, profoundly life-altering hormonal disorder that affects 8 to 13% of women of reproductive age globally. And despite its prevalence, up to 70% of those who have it remain undiagnosed.

If you are reading this because you have just received a diagnosis, because you have been struggling to conceive, or because you simply want to understand what is happening inside your body — you are in the right place. This is your comprehensive, compassionate, clinically grounded guide to PCOS and infertility.

---

Key Facts at a Glance

• 1 in 10 women of reproductive age are affected by PCOS worldwide
• Up to 70% of PCOS cases go undiagnosed
• PCOS is the number one cause of anovulatory (failure-to-ovulate) infertility
• Despite this, the majority of women with PCOS who seek treatment do successfully conceive

---

What Is PCOS? More Than Just “Cysts on the Ovaries”

The name “polycystic ovary syndrome” is, in many ways, a misnomer — and one that has caused decades of confusion for patients and even some healthcare providers. The word “polycystic” implies the primary feature is multiple cysts on the ovaries. In reality, the small follicles visible on ultrasound are not true cysts in the medical sense. They are immature follicles — eggs that have begun developing but stopped short of full maturation and release.

PCOS is, at its core, a hormonal and metabolic disorder. It is characterised by a constellation of issues: disrupted hormone signalling, irregular or absent ovulation, elevated androgens (male-type hormones) in the body, and a complex relationship with insulin resistance. It is not simply an “ovary problem.” It affects the whole endocrine system — from the brain’s hypothalamus, to the pituitary gland, to the pancreas, to the adrenal glands, and, yes, to the ovaries.

“PCOS is a syndrome — meaning it is defined by a cluster of signs and symptoms, not by a single biomarker or test. This is precisely why it is so frequently missed.”

The condition was first formally described by Stein and Leventhal in 1935, when they observed a group of women with amenorrhea (absent periods), obesity, and enlarged ovaries. Today, we understand it far more deeply — and we know that PCOS presents differently in different women. Some have all the “classic” features; others have only a subset.

The Rotterdam Criteria: How PCOS Is Diagnosed

The most widely accepted diagnostic framework is the Rotterdam Criteria, established in 2003. Under these criteria, a diagnosis of PCOS requires at least two of the following three features:

1. Oligo- or anovulation — Irregular, infrequent, or absent menstrual cycles, indicating that ovulation is not occurring normally.
2. Clinical or biochemical signs of hyperandrogenism — Elevated male hormones (androgens) in the blood, or their physical manifestations: excess facial or body hair (hirsutism), acne, or male-pattern hair thinning.
3. Polycystic ovarian morphology — Ovaries appearing on ultrasound to have 12 or more follicles measuring 2–9mm, or an ovarian volume greater than 10ml in either ovary.

Importantly, before a PCOS diagnosis is confirmed, other conditions that can mimic its symptoms must be ruled out — including thyroid disorders, hyperprolactinemia, congenital adrenal hyperplasia, and androgen-secreting tumours.

---

Recognising the Many Faces of PCOS

One of the reasons PCOS goes undiagnosed for so long is that its symptoms are remarkably diverse. No two women experience PCOS in exactly the same way, and many of the individual symptoms — acne, weight gain, fatigue — are so common in the general population that they are often dismissed or attributed to stress, diet, or “just getting older.”

Irregular or Absent Periods

Cycles longer than 35 days, fewer than 8 periods per year, or complete absence of menstruation (amenorrhea) are hallmark signs of PCOS-related anovulation.

Hirsutism (Excess Hair Growth)

Unwanted hair growth on the face, chest, back, or abdomen is caused by elevated androgens stimulating hair follicles. It affects up to 70% of women with PCOS and can be one of the most distressing symptoms psychologically.

Acne and Oily Skin

Hormonal acne that persists well into adulthood, often concentrated on the jawline, chin, and cheeks, is a very common complaint among women with PCOS.

Hair Thinning on the Scalp

Androgenic alopecia — thinning at the crown or temples, similar to male-pattern baldness — affects a significant proportion of women with PCOS and can be particularly distressing.

Weight Gain and Difficulty Losing Weight

Weight gain, particularly around the abdomen, is common in PCOS. Many women find weight very difficult to lose despite sustained healthy eating and exercise, due to the underlying insulin resistance driving the condition.

Insulin Resistance

The body’s cells do not respond well to insulin, leading to higher blood sugar levels, increased hunger, energy crashes, and an elevated long-term risk of type 2 diabetes.

Fatigue and Brain Fog

Chronic tiredness, difficulty concentrating, and low energy are frequently reported by women with PCOS, often linked to disrupted sleep, blood sugar instability, and metabolic imbalance.

Mood Disturbances

Women with PCOS have significantly higher rates of depression and anxiety compared to women without the condition. This is driven partly by hormonal fluctuations and partly by the psychological burden of managing the condition’s many visible and invisible symptoms.

Darkened Skin Patches

Acanthosis nigricans — velvety darkening of skin folds at the neck, armpits, or groin — is a classic visible sign of insulin resistance and is seen in some women with PCOS.

A Note on Lean PCOS

Not all women with PCOS are overweight. “Lean PCOS” — occurring in women with a normal or low BMI — affects roughly 20–30% of those with the condition. Lean PCOS can be harder to diagnose because the association between PCOS and weight causes many clinicians to overlook slimmer patients. Symptoms like irregular periods and elevated androgens are just as real and just as disruptive in lean women with PCOS.

---

What Is Actually Happening Inside the Body?

To understand how PCOS causes infertility, we need to understand how normal ovulation works — and precisely where that process breaks down.

The Normal Menstrual Cycle

Each month, the hypothalamus (a region in the brain) releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release two key hormones: follicle-stimulating hormone (FSH) and luteinising hormone (LH). FSH stimulates multiple follicles in the ovary to begin maturing, each containing an egg. Typically, one dominant follicle wins the race and continues to grow while the others recede. As the dominant follicle matures, it produces increasing amounts of oestrogen, which triggers a surge in LH — the signal for ovulation, the release of the mature egg.

After ovulation, the empty follicle becomes the corpus luteum, which produces progesterone to prepare the uterine lining for implantation. If the egg is not fertilised, the corpus luteum breaks down, progesterone drops, and menstruation begins — resetting the cycle.

How PCOS Disrupts This Cycle

Elevated LH and Abnormal GnRH Pulsing

Women with PCOS often have abnormally high LH levels relative to FSH. The ratio of LH to FSH, which is typically around 1:1, can be 2:1 or even 3:1 in PCOS. This imbalance impairs follicle development. Many follicles begin to develop but none can reach full maturity for ovulation — they stall at an intermediate stage, forming that characteristic “string of pearls” visible on ultrasound.

Insulin Resistance and Compensatory Hyperinsulinaemia

Approximately 70–80% of women with PCOS have some degree of insulin resistance, regardless of their weight. When cells resist insulin’s signals, the pancreas compensates by producing more insulin. High insulin levels directly stimulate the ovaries and adrenal glands to produce more androgens. Excess androgens then further disrupt follicle development and ovulation, creating a self-reinforcing cycle.

Elevated Androgens

High androgen levels have multiple damaging effects on the reproductive system. They interfere with the normal maturation of follicles, prevent the LH surge needed for ovulation, and may directly affect egg quality over time.

“The infertility of PCOS is primarily anovulatory — the problem is not that eggs cannot be produced, but that they cannot be released. This distinction matters enormously for treatment.”

The Role of Anti-Müllerian Hormone (AMH)

AMH is a hormone produced by granulosa cells in developing follicles. Women with PCOS typically have AMH levels two to four times higher than women without the condition, reflecting the much larger pool of antral follicles in their ovaries. While high AMH is often misinterpreted as being “extra fertile,” this is a misconception. High AMH in PCOS reflects follicular arrest — many follicles trapped in a state of incomplete development — rather than a larger reserve of healthy, ovulatable eggs.

---

PCOS and Infertility — The Path from Diagnosis to Difficulty Conceiving

PCOS is the single most common cause of anovulatory infertility — infertility resulting from the failure to ovulate. For women who ovulate rarely or not at all, the mathematical reality is stark: if you are only ovulating a few times a year rather than twelve, the number of opportunities to conceive is dramatically reduced. And because ovulation may be so irregular as to be unpredictable, even timed intercourse becomes a guessing game.

Egg Quality and the PCOS Ovarian Environment

Even when women with PCOS do ovulate — either naturally or through ovulation induction — there is evidence suggesting that the oocytes (eggs) produced may be of lower quality on average. The chronically elevated androgen environment within the PCOS ovary can affect the developmental competence of eggs, potentially reducing fertilisation rates and embryo quality. This is an active area of research, but it is a clinically relevant consideration.

Endometrial Receptivity

For a pregnancy to establish, the fertilised egg must implant successfully into the uterine lining (endometrium). In PCOS, the endometrium is often exposed to oestrogen for extended periods without the counterbalancing effect of progesterone, which is normally released after ovulation. This prolonged unopposed oestrogen exposure can disrupt the normal preparation of the uterine lining, potentially making it less receptive to implantation.

Miscarriage Risk

Multiple studies suggest that women with PCOS have a higher rate of early pregnancy loss compared to women without the condition. The reasons are likely multifactorial: egg quality issues, endometrial abnormalities, elevated LH at the time of conception, and insulin resistance all appear to contribute. Some research suggests that treatment of insulin resistance with metformin may reduce miscarriage rates in PCOS, though the evidence is still evolving.

Pregnancy Complications

Even when women with PCOS successfully conceive, the pregnancy itself carries additional risks. Compared to the general obstetric population, women with PCOS have higher rates of gestational diabetes, pregnancy-induced hypertension and pre-eclampsia, preterm birth, and caesarean delivery. Comprehensive prenatal care with early screening for these complications is essential.

A Note on Perspective

While the above information is important to be aware of, it is equally important to hold it in context. The majority of women with PCOS who receive appropriate treatment do conceive, and many go on to have healthy pregnancies. PCOS-related infertility, unlike some forms of infertility, is usually treatable. The fact that the primary problem is anovulation — rather than structural damage to the fallopian tubes or an absent uterus — means that medical interventions to restore or trigger ovulation are often highly effective.

---

Restoring Fertility — Evidence-Based Treatment Options

PCOS-related infertility is among the most treatable forms of infertility. Treatment is generally stepwise, moving from the least invasive interventions to more complex ones, and tailored to each woman’s specific hormonal profile, age, weight, and reproductive goals.

Step One: Lifestyle Modification

For women with PCOS who are overweight, even modest weight loss — as little as 5–10% of body weight — can have a profound impact on hormonal balance and fertility. Weight loss improves insulin sensitivity, reduces circulating androgens, and can spontaneously restore ovulation in a significant proportion of women. A diet focused on low glycaemic index foods, with adequate protein and healthy fats, appears particularly beneficial. Regular moderate exercise — not extreme regimens — further improves insulin sensitivity. For women who are already at a healthy weight, lifestyle optimisation still matters: sleep quality, stress management, and anti-inflammatory nutrition all support hormonal balance.

Letrozole: First-Line Ovulation Induction

Letrozole, an aromatase inhibitor originally developed as a breast cancer drug, is now the first-line medication for ovulation induction in PCOS. Clinical trials have demonstrated that letrozole results in higher ovulation rates, higher pregnancy rates, and higher live birth rates compared to clomiphene citrate in women with PCOS. It is typically taken for 5 days early in the cycle, and ovulation is monitored by ultrasound.

Clomiphene Citrate

The older standard of care for ovulation induction, clomiphene citrate (Clomid) is still widely used. It works by blocking oestrogen receptors in the brain, prompting the body to produce more FSH. It is effective in many women, though letrozole has now surpassed it as the preferred agent in most international guidelines.

Metformin

This insulin-sensitising medication, widely used in type 2 diabetes, addresses one of the root metabolic issues in PCOS. Metformin can restore ovulation in some women, improve cycle regularity, and may reduce miscarriage risk. It is often used alongside ovulation-inducing medications, and is particularly useful in women with significant insulin resistance.

Gonadotropin Injections

When oral medications are insufficient, injectable gonadotropins can directly stimulate the ovaries. These require careful monitoring with frequent ultrasounds and blood tests to minimise the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancy — risks that are higher in women with PCOS due to their large follicle reserve.

Laparoscopic Ovarian Drilling

A surgical option for women who have not responded to medication, laparoscopic ovarian drilling involves making small punctures in the ovarian tissue using electrocautery or laser. This destroys a small amount of androgen-producing ovarian tissue, reducing testosterone levels and often restoring ovulation. The effect can last for months to years. It is not a first-line treatment but has an important role in the overall treatment algorithm.

IVF (In Vitro Fertilisation)

For women who have not achieved pregnancy through ovulation induction, or who have additional fertility factors such as a male factor or tubal issues, IVF is highly effective. Women with PCOS typically respond vigorously to ovarian stimulation due to their large follicle pool, and are at elevated risk of OHSS. IVF protocols for PCOS are carefully tailored, often using “freeze-all” strategies — stimulating and freezing embryos in one cycle, then transferring a frozen embryo in a subsequent natural cycle to avoid hyperstimulation.

Inositol: The Supplement Evidence

Myo-inositol and D-chiro-inositol are naturally occurring compounds that act as insulin sensitisers. A growing body of evidence supports their use in PCOS to improve insulin resistance, reduce androgen levels, restore menstrual regularity, and improve egg quality. They are generally well tolerated and increasingly recommended as an adjunct to lifestyle modification. The most studied formulation is a 40:1 ratio of myo-inositol to D-chiro-inositol. Always discuss supplements with your healthcare provider before starting them.

---

The Emotional Weight of PCOS and Infertility

Medical articles about PCOS often read like lists: symptoms, hormones, treatments. But behind every datapoint is a woman — or a couple — navigating something deeply personal, often isolating, and sometimes heartbreaking.

Research consistently finds that women with PCOS experience significantly higher rates of depression and anxiety than those without the condition. This is not simply a response to the difficulty of getting pregnant. It predates fertility struggles for many women. The daily reality of PCOS — managing symptoms that affect how you look, how you feel, your energy, your cycle, your sense of femininity and normalcy — takes a genuine psychological toll.

“The grief of infertility is not always loud. Sometimes it is the quiet ache of seeing another pregnancy announcement, the hollow feeling of another negative test, the exhaustion of hope deferred month after month.”

When infertility enters the picture, the emotional complexity deepens. Fertility treatment is physically demanding — injections, monitoring appointments, hormonal fluctuations, procedures. It is financially draining in many healthcare systems. And the emotional rollercoaster of treatment cycles — hope, waiting, the crash of a negative result, the rebuilding of hope — is one of the most psychologically gruelling experiences a person can go through.

Protecting Your Mental Health

Seek Psychological Support Proactively, Not as a Last Resort

Fertility counselling — either individually or as a couple — has been shown to improve emotional wellbeing, reduce anxiety, and even improve treatment outcomes in some studies. Many fertility clinics now have integrated psychological support. If yours does not, ask for a referral.

Become an Informed Advocate for Yourself

Understanding your condition, knowing the right questions to ask, and actively participating in your treatment decisions reduces the feeling of helplessness that can compound anxiety. Knowledge is not just empowering — it is genuinely protective.

Find Your Community

The experience of PCOS and infertility can feel profoundly isolating, particularly if those around you conceive easily. Online communities, support groups, and patient advocacy organisations connect you with others who truly understand. This validation is not a small thing — it is a lifeline.

Set Boundaries Around Your Fertility Journey

You do not owe anyone an explanation of your reproductive choices or challenges. Learning to navigate intrusive questions from family and friends — and protecting your emotional energy in the process — is a skill worth developing.

Acknowledge Grief

Every failed cycle involves a loss. The grief that comes with infertility is real and legitimate. Societies often fail to recognise it as such — there are no rituals, no acknowledgement, no bereavement leave. But the grief is real. Allowing yourself to feel it, and seeking support in doing so, is not weakness. It is an essential part of the journey.

Supporting a Partner

PCOS and infertility affect couples, not just individuals. Partners often feel helpless — unsure how to help, concerned about saying the wrong thing, carrying their own grief while trying to be strong. Open, honest communication — even when it is difficult — is the foundation. Counselling as a couple can provide a structured space for processing shared grief and maintaining connection through a profoundly stressful experience.

---

PCOS Beyond Fertility — A Lifelong Condition

PCOS does not simply disappear once a woman has had children, or once she passes reproductive age. It is a lifelong metabolic and hormonal condition with implications that extend well beyond fertility.

Type 2 Diabetes

Women with PCOS have a significantly elevated risk of developing type 2 diabetes — estimates suggest three to seven times the risk of women without PCOS. The mechanism is straightforward: insulin resistance, which underlies most PCOS cases, is the primary precursor to type 2 diabetes. Regular blood glucose monitoring, lifestyle optimisation, and early intervention are essential preventive strategies.

Cardiovascular Disease

The metabolic profile of PCOS — insulin resistance, dyslipidaemia (abnormal cholesterol and triglycerides), hypertension, and central obesity — creates a cardiovascular risk cluster. Women with PCOS have higher rates of cardiovascular disease risk factors, and cardiovascular health should be actively monitored and managed throughout life.

Endometrial Cancer

The chronic absence of ovulation means that women with PCOS are often exposed to sustained oestrogen without progesterone. Over time, this unopposed oestrogen exposure can cause endometrial hyperplasia — a thickening and abnormal proliferation of the uterine lining — which carries a risk of progressing to endometrial cancer. This is why managing menstrual irregularity in PCOS is not merely a quality-of-life issue; it is a cancer prevention strategy. Women who are not having periods regularly are often prescribed progestin to periodically shed the uterine lining.

Sleep Apnoea

Often overlooked in the context of PCOS, obstructive sleep apnoea is substantially more common in women with PCOS — even in lean women — compared to the general female population. Elevated androgens appear to directly increase susceptibility. Sleep apnoea further worsens insulin resistance, cardiovascular risk, and mood. Any woman with PCOS experiencing significant fatigue, snoring, or non-restorative sleep should be evaluated by a specialist.

Long-Term PCOS Management: Key Steps

• Annual blood glucose and lipid monitoring
• Regular blood pressure checks
• Regular assessment of menstrual regularity and endometrial health
• Mental health screening for depression and anxiety
• Cardiovascular risk reduction through lifestyle and, where appropriate, medication
• Evaluation for sleep apnoea if symptoms are present

A multidisciplinary team approach — involving your GP, gynaecologist or endocrinologist, and ideally a dietitian — offers the best long-term outcomes.

---

What Science Is Learning About PCOS

PCOS research has accelerated significantly in the past decade, fuelled by growing recognition of its global burden and a long-overdue increase in research funding for women’s health conditions. Several promising frontiers are emerging.

The Genetic Architecture of PCOS

Genome-wide association studies have identified multiple genetic variants associated with PCOS, including genes involved in insulin signalling, LH receptor function, and androgen metabolism. While no single “PCOS gene” has been identified, the data confirm that PCOS has a strong heritable component — daughters and sisters of women with PCOS are significantly more likely to develop the condition themselves.

The Gut Microbiome Connection

Emerging research suggests that the gut microbiome — the vast ecosystem of bacteria living in the digestive tract — may play a role in PCOS. Women with PCOS show measurable differences in gut microbiome composition compared to controls, and these differences correlate with insulin resistance and androgen levels. Probiotic and prebiotic interventions are under active investigation as potential adjuncts to treatment.

In Utero Programming

A compelling hypothesis suggests that PCOS may have origins in the womb. Elevated androgen exposure during foetal development — perhaps due to a mother with PCOS or other causes — may programme the developing hormonal axis in ways that predispose female offspring to PCOS. Studies in animal models have reproduced PCOS-like features by exposing foetuses to androgens in utero, and some human epidemiological data support this theory.

New Frontiers in Treatment

Research is exploring several promising novel approaches. GLP-1 receptor agonists (like semaglutide, widely known as Ozempic and Wegovy) are showing significant promise in improving insulin sensitivity, reducing androgen levels, and restoring menstrual regularity in women with PCOS. Kisspeptin analogs are being studied as a way to more precisely regulate the hormonal signalling that drives ovulation. And precision medicine approaches — tailoring treatments to an individual’s specific hormonal, metabolic, and genetic profile — represent the direction of travel for PCOS management in the coming decade.

---

There Is Every Reason for Hope

PCOS is a condition that demands more from the women who live with it — more vigilance, more advocacy, more patience with a medical system that has historically underresearched and underserved them. The diagnosis can feel, at first, like a door closing.

But the evidence is clear: PCOS-related infertility is highly treatable. The majority of women who seek appropriate treatment conceive. Many do so without ever needing IVF. The tools available to reproductive endocrinologists and gynaecologists today — from simple lifestyle interventions to sophisticated assisted reproductive technologies — have genuinely transformed the outlook for women with PCOS who want to become mothers.

Beyond fertility, understanding your PCOS diagnosis is a gateway to better lifelong health — the kind of proactive, informed management that protects your heart, your metabolic health, your mood, and your quality of life for decades to come.

If you are at the beginning of this journey, know this: you are not alone. One in ten women shares this diagnosis. And the path forward, while sometimes difficult, is navigable — with the right medical support, the right information, and the determination to keep going.

---

Medical Disclaimer: This article is intended for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment options. Individual circumstances vary and your doctor is best placed to advise on what is right for you.